Matches in Wikidata for { <http://www.wikidata.org/entity/Q90030366> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q90030366 description "article scientifique publié en 2019" @default.
- Q90030366 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90030366 description "scientific article published on 18 April 2019" @default.
- Q90030366 description "wetenschappelijk artikel" @default.
- Q90030366 description "наукова стаття, опублікована 18 квітня 2019" @default.
- Q90030366 description "գիտական հոդված հրատարակված 2019 թվականի ապրիլի 18-ին" @default.
- Q90030366 name "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 name "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 type Item @default.
- Q90030366 label "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 label "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 prefLabel "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 prefLabel "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 P1433 Q90030366-5DEA57E2-5A5F-47B7-AD9A-67AC218E7345 @default.
- Q90030366 P1476 Q90030366-FB96E3EB-6A04-494C-80C0-898CC2812992 @default.
- Q90030366 P2093 Q90030366-22C5C125-B120-4397-9696-CFD13D861A83 @default.
- Q90030366 P2093 Q90030366-55DA9781-F19A-4A48-9816-EC2E20E38430 @default.
- Q90030366 P2093 Q90030366-9686476F-0EBA-44DF-8C15-068C191A53E6 @default.
- Q90030366 P2093 Q90030366-CA777325-4A85-4A28-92B4-AF4277334E45 @default.
- Q90030366 P2093 Q90030366-CE9DC823-F4AA-4034-855E-72ED7D96FE03 @default.
- Q90030366 P2093 Q90030366-E696FEEC-A18F-4272-853D-A2A8D48109E2 @default.
- Q90030366 P304 Q90030366-2293C02D-149E-4CE6-AFFD-22458FBE77FB @default.
- Q90030366 P31 Q90030366-0E4A0114-E13F-4831-86D5-BAA0E942E776 @default.
- Q90030366 P356 Q90030366-35032703-353C-476E-9948-DD116AC25357 @default.
- Q90030366 P478 Q90030366-504C63C4-F66D-4007-8FAC-145610B82BF3 @default.
- Q90030366 P577 Q90030366-AC1C4FB2-655E-4425-AAA2-ECB74D298EF1 @default.
- Q90030366 P698 Q90030366-5AAAB292-0A4E-41DF-A167-D9A47D9CA4BC @default.
- Q90030366 P356 J.EXPHEM.2019.04.001 @default.
- Q90030366 P698 31004744 @default.
- Q90030366 P1433 Q5421109 @default.
- Q90030366 P1476 "Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation" @default.
- Q90030366 P2093 "Laurie A Steiner" @default.
- Q90030366 P2093 "Michael Getman" @default.
- Q90030366 P2093 "Ryo Kurita" @default.
- Q90030366 P2093 "Tyler Couch" @default.
- Q90030366 P2093 "Yukio Nakamura" @default.
- Q90030366 P2093 "Zachary Murphy" @default.
- Q90030366 P304 "19-24.e4" @default.
- Q90030366 P31 Q13442814 @default.
- Q90030366 P356 "10.1016/J.EXPHEM.2019.04.001" @default.
- Q90030366 P478 "74" @default.
- Q90030366 P577 "2019-04-18T00:00:00Z" @default.
- Q90030366 P698 "31004744" @default.